Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Viking Therapeutics Inc., 3 years.
Viking Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | Viking Therapeutics Inc. | Grant or award | +3,150 | — | — |
| Oct 25, 2024 | Viking Therapeutics Inc. | Option exercise | +16,000 | $4.48 | $71,680 |
| Oct 25, 2024 | Viking Therapeutics Inc. | Open-market sale | −16,000 | $79.50 | $1,272,000 |
| Sep 20, 2024 | Viking Therapeutics Inc. | Option exercise | +10,300 | $1.19 | $12,257 |
| Sep 20, 2024 | Viking Therapeutics Inc. | Open-market sale | −10,300 | $69.50 | $715,850 |
| Aug 21, 2024 | Viking Therapeutics Inc. | Option exercise | +5,700 | $1.19 | $6,783 |
| Aug 21, 2024 | Viking Therapeutics Inc. | Open-market sale | −5,700 | $69.72 | $397,404 |
| Aug 19, 2024 | Viking Therapeutics Inc. | Option exercise | +16,000 | $3.33 | $53,280 |
| Aug 19, 2024 | Viking Therapeutics Inc. | Open-market sale | −2,500 | $60.01 | $150,025 |
| Aug 19, 2024 | Viking Therapeutics Inc. | Open-market sale | −3,047 | $61.13 | $186,263 |
| Aug 19, 2024 | Viking Therapeutics Inc. | Open-market sale | −4,509 | $61.86 | $278,927 |
| Aug 19, 2024 | Viking Therapeutics Inc. | Open-market sale | −2,055 | $63.15 | $129,773 |
| Aug 19, 2024 | Viking Therapeutics Inc. | Open-market sale | −2,388 | $64.10 | $153,071 |
| Aug 19, 2024 | Viking Therapeutics Inc. | Open-market sale | −1,501 | $64.88 | $97,385 |
| Aug 14, 2024 | Viking Therapeutics Inc. | Option exercise | +20,786 | $8.00 | $166,288 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.